1. Search Case laws by Section / Act / Rule β now available beyond Income Tax. GST and Other Laws Available


2. New: βIn Favour Ofβ filter added in Case Laws.
Try both these filters in Case Laws β
Just a moment...
1. Search Case laws by Section / Act / Rule β now available beyond Income Tax. GST and Other Laws Available


2. New: βIn Favour Ofβ filter added in Case Laws.
Try both these filters in Case Laws β
Press 'Enter' to add multiple search terms. Rules for Better Search
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
<h1>Pharma entrants urged to secure drug licences, GST, GMP compliance and strong contracts amid digital health and e-pharmacy risks</h1> A pharma knowledge hub expanded its guidance for entrants, emphasizing legal and compliance prerequisites for manufacturing, PCD/franchise and distribution businesses, including obtaining drug licences, GST registration, adherence to GMP, and staying current with regulatory changes; it highlights risks from non-compliance, the need for robust due diligence when selecting manufacturing or franchise partners, and careful drafting of franchise/territory agreements and marketing materials to avoid regulatory or liability exposure. The release also notes evolving regulatory issues tied to digital health, e-pharmacies and telemedicine, and includes a press-release disclaimer distancing the publisher from editorial responsibility.